netFormulary South East London Joint Medicines Formulary NHS
Guy's and St Thomas' NHS Foundation Trust
Kings College Hospital NHS Foundation Trust
Lewisham and Greenwich NHS Trust
 
 Search
 Formulary Chapter 13: Skin - Full Chapter
Chapter Links...
 Details...
13.05.01  Expand sub section  Preparations for eczema
Alitretinoin caps
View adult BNF View SPC online
Formulary
Red
High Cost Medicine
 
Link  NICE TA177: Eczema (chronic) - alitretinoin
   
Mycophenolate mofetil tabs, caps
View adult BNF View SPC online
Formulary
Amber 3
Approved off-label indications:
  • Severe immunobullous disease
  • Severe atopic dermatitis
  • Severe psoriasis Reasons for prescribing should be clearly communicated to the patient’s GP Restricted to use in patients patients unresponsive or intolerant of standard therapies. Use as a steroid-sparing immunosuppressant  
  •    
    Zinc paste and ichthammol bandage BP (Ichthopaste®)
    View adult BNF View SPC online
    Formulary  
       
    Zinc paste bandage BP (Viscopaste PB7®)
    View adult BNF View SPC online
    Formulary  
       
    Beclometasone dipropionate in WSP ointment 0.0025% (Propaderm ®)
    View adult BNF View SPC online
    Unlicensed Drug Unlicensed
    Amber 2
    BAD/APC Approved Special For eczema wet wraps in paediatrics only.  
       
    Ichthammol 1% w/w and zinc oxide 15% w/w in YSP
    View adult BNF View SPC online
    Unlicensed Drug Unlicensed
    Amber 2
    BAD/APC Approved Special For acutely inflamed atopic eczema.  
       
     ....
    Key
    note Notes
    Section Title Section Title (top level)
    Section Title Section Title (sub level)
    First Choice Item First Choice item
    Non Formulary Item Non Formulary section
    Restricted Drug
    Restricted Drug
    Unlicensed Drug
    Unlicensed
    Track Changes
    Display tracking information
    click to search medicines.org.uk
    Link to adult BNF
    click to search medicines.org.uk
    Link to SPCs
    SMC
    Scottish Medicines Consortium
    Cytotoxic Drug
    Cytotoxic Drug
    CD
    Controlled Drug
    High Cost Medicine
    High Cost Medicine
    Cancer Drugs Fund
    Cancer Drugs Fund
    NHSE
    NHS England
    Homecare
    Homecare
    CCG
    CCG

    Traffic Light Status Information

    Status Description

    Red

    Specialist or hospital prescribing only. The responsibility for prescribing, monitoring, dose adjustment and review should remain with the specialist or hospital. In very exceptional circumstances a specialist may discuss individual patient need for a RED drug to be prescribed by a GP and the GP should consider informing the Medicines Management team before a decision is made to prescribe for individual patients.   

    Amber 1

    Treatment can be initiated in primary care after a recommendation from an appropriate specialist  

    Amber 2

    Specialist initiation followed by maintenance prescribing in primary care  

    Amber 3

    Specialist initiation with ongoing monitoring required. After dose stabilisation GPs can be requested to take over prescribing responsibilities using the approved APC shared care documentation  

    Green

    Specialist and non-specialist initiation  

    Grey

    Not recommended for prescribing  

    netFormulary